Tetrahydroporphyrin-tetratosylate (THPTS)-based photodynamic inactivation of critical multidrug-resistant bacteria in vitro.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 18 11 2019
revised: 15 03 2020
accepted: 03 04 2020
pubmed: 24 4 2020
medline: 24 3 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

Photodynamic inactivation (PDI) is a promising approach to treat multidrug-resistant infections. However, effectiveness of PDI is limited, particularly in Gram-negative bacteria. The use of photosensitizer (PS) 3,3',3'',3'''-(7,8,17,18-tetrahydro-21H,23H-porphyrine-5,10,15,20-tetrayl)tetrakis[1-methyl-pyridinium]tetratosylate (THPTS) and laser light has led to very promising results. This study focuses on the effects of THPTS in various critical multidrug-resistant bacterial strains and explores the possibility of light-emitting diode (LED)-based activation as a clinically more feasible alternative to laser light. THPTS was further chemically characterized and in vitro testing of PDI of different multidrug-resistant bacterial strains was performed under various experimental conditions, including varying drug concentration, incubation time, light source (laser and LED) and light intensity, by determination of viable bacteria after treatment. The effect of hyaluronic acid as an adjuvant for medical applications was also evaluated. Bacterial density of all investigated bacterial strains was reduced by several orders of magnitude, irrespective of multidrug-resistance or hyaluronic acid addition. The effect was less intense in Gram-negative strains (disinfection), and more pronounced in Gram-positive strains (sterilization), even at reduced THPTS concentrations or decreased light treatment intensity. Controls without THPTS or without light treatment did not indicate reduced bacterial density. PDI with THPTS and laser light was effective in all investigated bacterial strains. Gram-negative strains were less, but sufficiently, susceptible to PDI. Adding hyaluronic acid did not reduce the antibacterial treatment effect. LED-based PDI is equally effective when illumination duration is increased to compensate for reduced light intensity.

Sections du résumé

BACKGROUND BACKGROUND
Photodynamic inactivation (PDI) is a promising approach to treat multidrug-resistant infections. However, effectiveness of PDI is limited, particularly in Gram-negative bacteria. The use of photosensitizer (PS) 3,3',3'',3'''-(7,8,17,18-tetrahydro-21H,23H-porphyrine-5,10,15,20-tetrayl)tetrakis[1-methyl-pyridinium]tetratosylate (THPTS) and laser light has led to very promising results. This study focuses on the effects of THPTS in various critical multidrug-resistant bacterial strains and explores the possibility of light-emitting diode (LED)-based activation as a clinically more feasible alternative to laser light.
METHODS METHODS
THPTS was further chemically characterized and in vitro testing of PDI of different multidrug-resistant bacterial strains was performed under various experimental conditions, including varying drug concentration, incubation time, light source (laser and LED) and light intensity, by determination of viable bacteria after treatment. The effect of hyaluronic acid as an adjuvant for medical applications was also evaluated.
RESULTS RESULTS
Bacterial density of all investigated bacterial strains was reduced by several orders of magnitude, irrespective of multidrug-resistance or hyaluronic acid addition. The effect was less intense in Gram-negative strains (disinfection), and more pronounced in Gram-positive strains (sterilization), even at reduced THPTS concentrations or decreased light treatment intensity. Controls without THPTS or without light treatment did not indicate reduced bacterial density.
CONCLUSIONS CONCLUSIONS
PDI with THPTS and laser light was effective in all investigated bacterial strains. Gram-negative strains were less, but sufficiently, susceptible to PDI. Adding hyaluronic acid did not reduce the antibacterial treatment effect. LED-based PDI is equally effective when illumination duration is increased to compensate for reduced light intensity.

Identifiants

pubmed: 32325201
pii: S0924-8579(20)30133-3
doi: 10.1016/j.ijantimicag.2020.105976
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Photosensitizing Agents 0
Porphyrins 0
tetrahydroporphyrin tetratosylate 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105976

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Svitlana Ziganshyna (S)

Department of Anesthesiology and Intensive Care, University of Leipzig, Medical Faculty, Leipzig, Germany.

Anna Guttenberger (A)

Department of Anesthesiology and Intensive Care, University of Leipzig, Medical Faculty, Leipzig, Germany.

Norman Lippmann (N)

Institute of Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Medical Faculty, Leipzig, Germany.

Sebastian Schulz (S)

Department of Anesthesiology and Intensive Care, University of Leipzig, Medical Faculty, Leipzig, Germany.

Sven Bercker (S)

Department of Anesthesiology and Intensive Care, University of Leipzig, Medical Faculty, Leipzig, Germany.

Axel Kahnt (A)

Leibniz Institute of Surface Engineering (IOM), Leipzig, Germany.

Tobias Rüffer (T)

Institute of Chemistry, Faculty of Natural Sciences, Technical University of Chemnitz, Chemnitz, Germany.

Alexander Voigt (A)

Institute of Chemistry, Faculty of Natural Sciences, Technical University of Chemnitz, Chemnitz, Germany.

Khrystyna Gerlach (K)

Institute of Chemistry, Faculty of Natural Sciences, Technical University of Chemnitz, Chemnitz, Germany.

Robert Werdehausen (R)

Department of Anesthesiology and Intensive Care, University of Leipzig, Medical Faculty, Leipzig, Germany. Electronic address: werdehausen@medizin.uni-leipzig.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH